These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 16552415)

  • 1. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic behavior and reversible inhibition of monoamine oxidases--enzymes that many want dead.
    Tipton KF; Davey GP; McDonald AG
    Int Rev Neurobiol; 2011; 100():43-64. PubMed ID: 21971002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases.
    Rahman T; Rahmatullah M
    Bioorg Med Chem Lett; 2010 Jan; 20(2):537-40. PubMed ID: 19969454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides.
    Manley-King CI; Terre'Blanche G; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2009 Apr; 17(8):3104-10. PubMed ID: 19324554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant secondary metabolites- potent inhibitors of monoamine oxidase isoforms.
    Mathew B; Suresh J; Mathew GE; Parasuraman R; Abdulla N
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):28-33. PubMed ID: 25142815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
    La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the discovery of a novel class of monoamine oxidase inhibitors: structure-property-activity and docking studies on chromone amides.
    Gaspar A; Teixeira F; Uriarte E; Milhazes N; Melo A; Cordeiro MN; Ortuso F; Alcaro S; Borges F
    ChemMedChem; 2011 Apr; 6(4):628-32. PubMed ID: 21442758
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.
    Hassan SY; Khattab SN; Bekhit AA; Amer A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors.
    Secci D; Carradori S; Bolasco A; Bizzarri B; D'Ascenzio M; Maccioni E
    Curr Top Med Chem; 2012; 12(20):2240-57. PubMed ID: 23276158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase A and B substrates: probing the pathway for drug development.
    Chajkowski-Scarry S; Rimoldi JM
    Future Med Chem; 2014 Apr; 6(6):697-717. PubMed ID: 24895896
    [No Abstract]   [Full Text] [Related]  

  • 12. Modeling of substrate-binding region of the active site of monoamine oxidase A.
    Veselovsky AV; Medvedev AE; Tikhonova OV; Skvortsov VS; Ivanov AS
    Biochemistry (Mosc); 2000 Aug; 65(8):910-6. PubMed ID: 11002183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
    Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
    Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold.
    Matos MJ; Viña D; Vazquez-Rodriguez S; Uriarte E; Santana L
    Curr Top Med Chem; 2012; 12(20):2210-39. PubMed ID: 23231397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited.
    Holt A; Berry MD; Boulton AA
    Neurotoxicology; 2004 Jan; 25(1-2):251-66. PubMed ID: 14697900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors.
    Chimenti F; Bolasco A; Secci D; Chimenti P; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
    Bioorg Med Chem; 2010 Aug; 18(15):5715-23. PubMed ID: 20615716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of monoamine oxidase inhibitors in chronic neurodegeneration.
    Riederer P; Müller T
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):233-240. PubMed ID: 27998194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eugenol and its structural analogs inhibit monoamine oxidase A and exhibit antidepressant-like activity.
    Tao G; Irie Y; Li DJ; Keung WM
    Bioorg Med Chem; 2005 Aug; 13(15):4777-88. PubMed ID: 15936201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.
    Alcaro S; Gaspar A; Ortuso F; Milhazes N; Orallo F; Uriarte E; Yáñez M; Borges F
    Bioorg Med Chem Lett; 2010 May; 20(9):2709-12. PubMed ID: 20382016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.